The Leadership Team at Alector is responsible for guiding the strategic direction and operational management of the company. Comprising senior executives from finance, legal, clinical development, and scientific research, the team collaborates to oversee the development of innovative therapies, ensure regulatory compliance, and optimize financial performance, ultimately driving Alector's mission to advance neuroimmunology and improve patient outcomes.
Arnon Rosenthal
CEO
Calvin Yu
VP of Finance
Daniel Maslyar
Vice President of Clinical Dev...
George Demos
Vice President
Giacomo Salvadore
Senior Vice President, Head Of...
Lawrence Carter
Vice President Of Clinical Dev...
Omer Siddiqui
VP of Development Operations
Robert Paul
Chief Medical Officer
Sabah Oney
Chief Business Officer
Stephanie Yonker
VP of Legal